In summary, our study comprehensively investigates the origins, metabolic profiles, and clinical implications of gliomas across different grades, highlighting the significant role of the metabolism-associated enzyme PDE8B as both a biomarker and a driver of glioma progression. This evidence concerns the gene PDE8B and glioma.